Proteome Sciences (LON:PRM) Stock Price Down 0.6% – Here’s What Happened

Proteome Sciences plc (LON:PRM)’s share price was down 0.6% on Monday . The company traded as low as GBX 1.50 and last traded at GBX 1.70. Approximately 657,337 shares changed hands during mid-day trading, an increase of 54% from the average daily volume of 425,694 shares. The stock had previously closed at GBX 1.71.

Proteome Sciences Price Performance

The company has a current ratio of 0.13, a quick ratio of 0.37 and a debt-to-equity ratio of -165.46. The stock has a market cap of £5.19 million, a price-to-earnings ratio of -1.42 and a beta of 0.07. The stock has a 50-day moving average price of GBX 1.59 and a two-hundred day moving average price of GBX 1.96.

Proteome Sciences (LON:PRM) last posted its quarterly earnings data on Wednesday, April 15th. The company reported GBX (1.04) earnings per share for the quarter. The business had revenue of GBX 376 million during the quarter. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.